The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
β-Site Amyloid Precursor Protein (APP)-cleaving Enzyme 1 (BACE1)-deficient Mice Exhibit a Close Homolog of L1 (CHL1) Loss-of-function Phenotype Involving Axon Guidance Defects
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
BACE1 is highly expressed in the nervous system and contributes to additional physiological processes besides its role in AD, e.g., through neuregulin-1 cleavage in myelination and CHL1 cleavage in axon targeting.
“BACE1 is highly expressed in the nervous system and contributes to additional physiological processes besides its role in AD, e.g. through neuregulin-1 cleavage in myelination and CHL1 cleavage in axon targeting [7–12].”
From Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons (2016) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Self-citationCitron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757
A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
Jonsson, T., Atwal, J. K., Steinberg, S., Snaedal, J., Jonsson, P. V., Bjornsson, S., Stefansson, H., Sulem, P., Gudbjartsson, D., Maloney, J., et al. (2012) · Nature · doi:10.1038/nature11283 · Cited by 1,738
Control of Peripheral Nerve Myelination by the ß-Secretase BACE1
Willem, M., Garratt, A. N., Novak, B., Citron, M., Kaufmann, S., Rittger, A., DeStrooper, B., Saftig, P., Birchmeier, C., & Haass, C. (2006) · Science · doi:10.1126/science.1132341 · Cited by 703
γ-Secretase, notch, Aβ and alzheimer's disease: Where do the presenilins fit in?
Sisodia, S. S., & St George-Hyslop, P. H. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn785 · Cited by 512
McConlogue, L., Buttini, M., Anderson, J. P., Brigham, E. F., Chen, K. S., Freedman, S. B., Games, D., Johnson-Wood, K., Lee, M., Zeller, M., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611687200 · Cited by 300 · cited 1×
“Based on ADmouse model studies, it is hypothesized that 50% BACE1 inhibition is necessary to delay or prevent amyloid deposition (17, 57).”
MethodSavonenko, A. V., Melnikova, T., Laird, F. M., Stewart, K.-A., Price, D. L., & Wong, P. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710373105 · Cited by 290
BACE1 Deficiency Causes Altered Neuronal Activity and Neurodegeneration
Hu, X., Zhou, X., He, W., Yang, J., Xiong, W., Wong, P., Wilson, C. G., & Yan, R. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1334-10.2010 · Cited by 162
Flagged first, then by citations
Research works printed but not linked: 49
- Rajapaksha, 2011, The Alzheimer β-secretase enzyme BACE1 is required for accurate axon guidance of olfactory sensory neurons and normal glomerulus formation in the olfactory bulb, Mol. Neurodegener., 6, 88, 10.1186/1750-1326-6-88 · DOI
- Tanzi, 2005, Twenty years of the Alzheimer disease amyloid hypothesis. A genetic perspective, Cell, 120, 545, 10.1016/j.cell.2005.02.008 · DOI · Paper page
- Yan, 1999, Membrane-anchored aspartyl protease with Alzheimer disease β-secretase activity, Nature, 402, 533, 10.1038/990107 · DOI · Paper page
- Sinha, 1999, Purification and cloning of amyloid precursor protein β-secretase from human brain, Nature, 402, 537, 10.1038/990114 · DOI · Paper page
- Hussain, 1999, Identification of a novel aspartic protease (Asp-2) as β-secretase, Mol. Cell. Neurosci., 14, 419, 10.1006/mcne.1999.0811 · DOI · Paper page
- Lin, 2000, Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein, Proc. Natl. Acad. Sci. U.S.A., 97, 1456, 10.1073/pnas.97.4.1456 · DOI
- Di Fede, 2009, A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis, Science, 323, 1473, 10.1126/science.1168979 · DOI
- Giaccone, 2010, Neuropathology of the recessive A673V APP mutation. Alzheimer disease with distinctive features, Acta Neuropathol., 120, 803, 10.1007/s00401-010-0747-1 · DOI · Paper page
- Luo, 2001, Mice deficient in BACE1, the Alzheimer β-secretase, have normal phenotype and abolished β-amyloid generation, Nat. Neurosci., 4, 231, 10.1038/85059 · DOI · Paper page
- Roberds, 2001, BACE knockout mice are healthy despite lacking the primary β-secretase activity in brain. Implications for Alzheimer disease therapeutics, Hum. Mol. Genet., 10, 1317, 10.1093/hmg/10.12.1317 · DOI · Paper page
- Cai, 2001, BACE1 is the major β-secretase for generation of Aβ peptides by neurons, Nat. Neurosci., 4, 233, 10.1038/85064 · DOI
- Ohno, 2004, BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer disease, Neuron, 41, 27, 10.1016/S0896-6273(03)00810-9 · DOI · Paper page
- Laird, 2005, BACE1, a major determinant of selective vulnerability of the brain to amyloid-β amyloidogenesis, is essential for cognitive, emotional, and synaptic functions, J. Neurosci., 25, 11693, 10.1523/JNEUROSCI.2766-05.2005 · DOI · Paper page
- Ohno, 2006, Temporal memory deficits in Alzheimer mouse models. Rescue by genetic deletion of BACE1, Eur. J. Neurosci., 23, 251, 10.1111/j.1460-9568.2005.04551.x · DOI · Paper page
- Hu, 2006, Bace1 modulates myelination in the central and peripheral nervous system, Nat. Neurosci., 9, 1520, 10.1038/nn1797 · DOI · Paper page
- Dominguez, 2005, Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice, J. Biol. Chem., 280, 30797, 10.1074/jbc.M505249200 · DOI
- Hitt, 2010, BACE1−/− mice exhibit seizure activity that does not correlate with sodium channel level or axonal localization, Mol. Neurodegener., 5, 31, 10.1186/1750-1326-5-31 · DOI · Paper page
- Cao, 2012, The precision of axon targeting of mouse olfactory sensory neurons requires the BACE1 protease, Sci. Rep., 2, 231, 10.1038/srep00231 · DOI
- Vassar, 2009, The β-secretase enzyme BACE in health and Alzheimer disease. Regulation, cell biology, function, and therapeutic potential, J. Neurosci., 29, 12787, 10.1523/JNEUROSCI.3657-09.2009 · DOI · Paper page
- Hemming, 2009, Identification of β-secretase (BACE1) substrates using quantitative proteomics, PLoS One, 4, e8477, 10.1371/journal.pone.0008477 · DOI
- Zhou, 2012, The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in vivo, J. Biol. Chem., 287, 25927, 10.1074/jbc.M112.377465 · DOI · Paper page
- Kuhn, 2012, Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons, EMBO J., 31, 3157, 10.1038/emboj.2012.173 · DOI · Paper page
- Zhao, 2007, β-Site amyloid precursor protein-cleaving enzyme 1 levels become elevated in neurons around amyloid plaques. Implications for Alzheimer disease pathogenesis, J. Neurosci., 27, 3639, 10.1523/JNEUROSCI.4396-06.2007 · DOI · Paper page
- Montag-Sallaz, 2002, Misguided axonal projections, neural cell adhesion molecule 180 mRNA up-regulation, and altered behavior in mice deficient for the close homolog of L1, Mol. Cell. Biol., 22, 7967, 10.1128/MCB.22.22.7967-7981.2002 · DOI
- Heyden, 2008, Abnormal axonal guidance and brain anatomy in mouse mutants for the cell recognition molecules close homolog of L1 and NgCAM-related cell adhesion molecule, Neuroscience, 155, 221, 10.1016/j.neuroscience.2008.04.080 · DOI
- Potter, 2001, Structure and emergence of specific olfactory glomeruli in the mouse, J. Neurosci., 21, 9713, 10.1523/JNEUROSCI.21-24-09713.2001 · DOI
- Bennett, 2000, A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer β-secretase, J. Biol. Chem., 275, 37712, 10.1074/jbc.M005339200 · DOI
- Crusio, 2005, Learning spatial orientation tasks in the radial maze and structural variation in the hippocampus in inbred mice, Behav. Brain Funct., 1, 3, 10.1186/1744-9081-1-3 · DOI
- O'Leary, 2005, Mechanisms of retinotopic map development. Ephs, ephrins, and spontaneous correlated retinal activity, Prog. Brain Res., 147, 43, 10.1016/S0079-6123(04)47005-8 · DOI
- Galimberti, 2010, EphA4 signaling in juveniles establishes topographic specificity of structural plasticity in the hippocampus, Neuron, 65, 627, 10.1016/j.neuron.2010.02.016 · DOI
- Xu, 2009, Ephrin-B3 reverse signaling through Grb4 and cytoskeletal regulators mediates axon pruning, Nat. Neurosci., 12, 268, 10.1038/nn.2254 · DOI
- Inoue, 2009, Synaptic activity prompts γ-secretase-mediated cleavage of EphA4 and dendritic spine formation, J. Cell Biol., 185, 551, 10.1083/jcb.200809151 · DOI
- Guaiquil, 2010, ADAM8 is a negative regulator of retinal neovascularization and of the growth of heterotopically injected tumor cells in mice, J. Mol. Med., 88, 497, 10.1007/s00109-010-0591-8 · DOI
- Guaiquil, 2009, ADAM9 is involved in pathological retinal neovascularization, Mol. Cell. Biol., 29, 2694, 10.1128/MCB.01460-08 · DOI
- Sisodia, 1992, β-Amyloid precursor protein cleavage by a membrane-bound protease, Proc. Natl. Acad. Sci. U.S.A., 89, 6075, 10.1073/pnas.89.13.6075 · DOI
- Pasquale, 2004, Eph-ephrin promiscuity is now crystal clear, Nat. Neurosci., 7, 417, 10.1038/nn0504-417 · DOI
- Davis, 1994, Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity, Science, 266, 816, 10.1126/science.7973638 · DOI
- Stein, 1998, Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses, Genes Dev., 12, 667, 10.1101/gad.12.5.667 · DOI
- Schmid, 2008, L1 and NCAM adhesion molecules as signaling coreceptors in neuronal migration and process outgrowth, Curr. Opin. Neurobiol., 18, 245, 10.1016/j.conb.2008.07.015 · DOI
- Dahme, 1997, Disruption of the mouse L1 gene leads to malformations of the nervous system, Nat. Genet., 17, 346, 10.1038/ng1197-346 · DOI
- Demyanenko, 1999, Abnormalities in neuronal process extension, hippocampal development, and the ventricular system of L1 knockout mice, J. Neurosci., 19, 4907, 10.1523/JNEUROSCI.19-12-04907.1999 · DOI
- Fransen, 1998, L1 knockout mice show dilated ventricles, vermis hypoplasia, and impaired exploration patterns, Hum. Mol. Genet., 7, 999, 10.1093/hmg/7.6.999 · DOI
- Naus, 2004, Ectodomain shedding of the neural recognition molecule CHL1 by the metalloprotease-disintegrin ADAM8 promotes neurite outgrowth and suppresses neuronal cell death, J. Biol. Chem., 279, 16083, 10.1074/jbc.M400560200 · DOI
- Maretzky, 2005, L1 is sequentially processed by two differently activated metalloproteases and presenilin/γ-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth, Mol. Cell. Biol., 25, 9040, 10.1128/MCB.25.20.9040-9053.2005 · DOI
- Yan, 2007, β-Secretase expression in normal and functionally deprived rat olfactory bulbs. Inverse correlation with oxidative metabolic activity, J. Comp. Neurol., 501, 52, 10.1002/cne.21239 · DOI
- Schlatter, 2008, CHL1 promotes Sema3A-induced growth cone collapse and neurite elaboration through a motif required for recruitment of ERM proteins to the plasma membrane, J. Neurochem., 104, 731, 10.1111/j.1471-4159.2007.05013.x · DOI
- Wright, 2007, Close homolog of L1 and neuropilin 1 mediate guidance of thalamocortical axons at the ventral telencephalon, J. Neurosci., 27, 13667, 10.1523/JNEUROSCI.2888-07.2007 · DOI
- Castellani, 2000, Analysis of the L1-deficient mouse phenotype reveals cross-talk between Sema3A and L1 signaling pathways in axonal guidance, Neuron, 27, 237, 10.1016/S0896-6273(00)00033-7 · DOI
- Castellani, 2002, Cis and trans interactions of L1 with neuropilin-1 control axonal responses to semaphorin 3A, EMBO J., 21, 6348, 10.1093/emboj/cdf645 · DOI
Cited by
Sorted by citations
Sharma, P., Srivastava, P., Seth, A., Tripathi, P. N., Banerjee, A. G., & Shrivastava, S. K. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.006 · Cited by 331
Kandalepas, P. C., Sadleir, K. R., Eimer, W. A., Zhao, J., Nicholson, D. A., & Vassar, R. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1152-3 · Cited by 240
Self-citationAβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level
Sadleir, K. R., Eimer, W. A., Cole, S. L., & Vassar, R. (2015) · Molecular Neurodegeneration · doi:10.1186/1750-1326-10-1 · Cited by 213
May, P. C., Willis, B. A., Lowe, S. L., Dean, R. A., Monk, S. A., Cocke, P. J., Audia, J. E., Boggs, L. N., Borders, A. R., Brier, R. A., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.4129-14.2015 · Cited by 206
Mahan, T. E., Wang, C., Bao, X., Choudhury, A., Ulrich, J. D., & Holtzman, D. M. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00516-0 · Cited by 134
Investigational BACE inhibitors for the treatment of Alzheimer’s disease
Imbimbo, B. P., & Watling, M. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1683160 · Cited by 132
Pigoni, M., Wanngren, J., Kuhn, P.-H., Munro, K. M., Gunnersen, J. M., Takeshima, H., Feederle, R., Voytyuk, I., De Strooper, B., Levasseur, M. D., et al. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0134-z · Cited by 125
Zhu, K., Xiang, X., Filser, S., Marinković, P., Dorostkar, M. M., Crux, S., Neumann, U., Shimshek, D. R., Rammes, G., Haass, C., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.12.023 · Cited by 107
miR‐186 is decreased in aged brain and suppresses BACE 1 expression
Kim, J., Yoon, H., Chung, D., Brown, J. L., Belmonte, K. C., & Kim, J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13507 · Cited by 102
“Complete loss of Bace1 in mice are known to lead to schizophrenia-like phenotypes and deficits in cognitive function, mossy fiber long-term potentiation, synaptic plasticity, and axon guidance (Savonenko et al. 2008; Wang et al. 2008a; Rajapaksha et al. 2011; Hitt et al. 2012; Petrus and Lee 2014).”
BackgroundAxonal organization defects in the hippocampus of adult conditional BACE1 knockout mice
Ou-Yang, M.-H., Kurz, J. E., Nomura, T., Popovic, J., Rajapaksha, T. W., Dong, H., Contractor, A., Chetkovich, D. M., Tourtellotte, W. G., & Vassar, R. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aao5620 · Cited by 94
Self-citationModulation of γ- and β-secretases as early prevention against Alzheimer's disease
Voytyuk, I., De Strooper, B., & Chávez-Gutiérrez, L. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.08.001 · Cited by 67
Machauer, R., Lueoend, R., Hurth, K., Veenstra, S. J., Rueeger, H., Voegtle, M., Tintelnot-Blomley, M., Rondeau, J.-M., Jacobson, L. H., Laue, G., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01300 · Cited by 40
Kim, W., Ma, L., Lomoio, S., Willen, R., Lombardo, S., Dong, J., Haydon, P. G., & Tesco, G. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0239-7 · Cited by 32
Versatile nanomaterials for Alzheimer’s disease: Pathogenesis inspired disease-modifying therapy
Xi, Y., Chen, Y., Jin, Y., Han, G., Song, M., Song, T., Shi, Y., Tao, L., Huang, Z., Zhou, J., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.02.034 · Cited by 27
Metadata
- Authors
- Hitt, B., Riordan, S. M., Kukreja, L., Eimer, W. A., Rajapaksha, T. W., & Vassar, R.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2012-11
- Volume
- 287
- Issue
- 46
- Pages
- 38408-38425
- ISSN
- 0021-9258
- Cited by
- 143
- References
- 8
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review